• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症评分系统中,多种合并症是否像在SCORTEN中那样被低估?

Are Multimorbidities Underestimated in Scoring Systems of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Like in SCORTEN?

作者信息

von Wild Tobias, Stollwerck Peter L, Namdar Thomas, Stang Felix H, Mailänder Peter, Siemers Frank

机构信息

Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.

出版信息

Eplasty. 2012;12:e35. Epub 2012 Aug 2.

PMID:22912906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411276/
Abstract

OBJECTIVE

Toxic epidermal necrolysis and Stevens-Johnson syndrome have related high morbidity and mortality. We predict that preexisting multimorbidity is a major prognostic factor of both these diseases.

METHODS

A retrospective analysis in toxic epidermal necrolysis and Stevens-Johnson syndrome patients over the past 10 years. Three severity categories (minor, moderate, and severe multimorbidity) were defined according to a point-rating system.

RESULTS

Twenty-seven inpatients, with a median age of 63 years, diagnosed with toxic epidermal necrolysis (n = 13) or Stevens-Johnson syndrome/toxic epidermal necrolysis (n = 14) were assessed in this study. Of these, 14 patients died during the course of the study. Nonsurvivors showed significantly higher multimorbidity (P = .038), with higher scoring on the points system for disease severity (P = .003), than survivors and CART (Classification and Regression Trees) cross-validation (P < .05).

LIMITATIONS

Restricted number of patients due to low prevalence rate.

CONCLUSION

The complexity of associated multimorbidity appears to have a large influence on toxic epidermal necrolysis and Stevens-Johnson syndrome prognosis, which has not been considered in any of the established scoring systems.

摘要

目的

中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征具有较高的发病率和死亡率。我们预测,预先存在的多种疾病是这两种疾病的主要预后因素。

方法

对过去10年中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征患者进行回顾性分析。根据评分系统定义了三个严重程度类别(轻度、中度和重度多种疾病)。

结果

本研究评估了27名住院患者,中位年龄为63岁,诊断为中毒性表皮坏死松解症(n = 13)或史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症(n = 14)。其中,14名患者在研究过程中死亡。与幸存者相比,非幸存者的多种疾病发生率显著更高(P = .038),疾病严重程度评分系统得分更高(P = .003),且分类回归树交叉验证结果显示差异有统计学意义(P < .05)。

局限性

由于患病率低,患者数量有限。

结论

相关多种疾病的复杂性似乎对中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征的预后有很大影响,而在任何既定的评分系统中均未考虑这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/35a99a65661f/eplasty12e35_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/c08de0f78f5d/eplasty12e35_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/82dd0aa4f646/eplasty12e35_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/35a99a65661f/eplasty12e35_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/c08de0f78f5d/eplasty12e35_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/82dd0aa4f646/eplasty12e35_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d87/3411276/35a99a65661f/eplasty12e35_fig3.jpg

相似文献

1
Are Multimorbidities Underestimated in Scoring Systems of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Like in SCORTEN?史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症评分系统中,多种合并症是否像在SCORTEN中那样被低估?
Eplasty. 2012;12:e35. Epub 2012 Aug 2.
2
Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.环孢素与支持性治疗在史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中的有效性、安全性和耐受性:一项基于记录的研究。
Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):312-316. doi: 10.4103/ijdvl.IJDVL_201_16.
3
Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症确诊患者的评估:单中心经验
Turk Pediatri Ars. 2016 Sep 1;51(3):152-158. doi: 10.5152/TurkPediatriArs.2016.3836. eCollection 2016 Sep.
4
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.与选择性环氧化酶-2抑制剂相关的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症报告情况的比较。
Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008.
5
Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.ABCD-10和SCORTEN死亡率预测模型在史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者队列中的表现。
J Am Acad Dermatol. 2021 Oct;85(4):873-877. doi: 10.1016/j.jaad.2021.04.082. Epub 2021 Apr 30.
6
Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.重症多形红斑、史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床模式与病因之间的相关性:一项国际前瞻性研究的结果
Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019.
7
Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.评估卡马西平和奥卡西平相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症:从 FDA 不良事件报告系统公开版本中挖掘数据。
Int J Clin Pract. 2021 Aug;75(8):e14273. doi: 10.1111/ijcp.14273. Epub 2021 May 17.
8
Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.比较 ABCD-10 和 SCORTEN 在预测 Stevens-Johnson 综合征/中毒性表皮坏死松解症住院死亡率中的准确性:来自中国中部的多机构研究。
Dermatology. 2022;238(4):736-744. doi: 10.1159/000520494. Epub 2021 Dec 7.
9
Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.多形红斑/史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症疾病谱的急性眼部表现分析
Ophthalmology. 1995 Nov;102(11):1669-76. doi: 10.1016/s0161-6420(95)30811-1.
10
Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.药物作为儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的危险因素:一项汇总分析。
Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.

引用本文的文献

1
Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.静脉注射免疫球蛋白联合皮质类固醇治疗史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症:中国一项倾向匹配的回顾性研究
Front Pharmacol. 2022 Jan 18;12:750173. doi: 10.3389/fphar.2021.750173. eCollection 2021.
2
Cutaneous Drug Reactions in the Elderly.老年人的皮肤药物反应
Drugs Aging. 2017 Sep;34(9):655-672. doi: 10.1007/s40266-017-0483-5.
3
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.

本文引用的文献

1
Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.对纳入RegiSCAR研究的一组史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者进行SCORTEN评估。
J Burn Care Res. 2011 Mar-Apr;32(2):237-45. doi: 10.1097/BCR.0b013e31820aafbc.
2
Defining comorbidity: implications for understanding health and health services.定义共病:对理解健康和卫生服务的影响。
Ann Fam Med. 2009 Jul-Aug;7(4):357-63. doi: 10.1370/afm.983.
3
Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy.
史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床特征及治疗结果
Exp Ther Med. 2015 Aug;10(2):519-524. doi: 10.3892/etm.2015.2549. Epub 2015 Jun 5.
4
Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症:亚太地区视角
Asia Pac Allergy. 2013 Oct;3(4):215-23. doi: 10.5415/apallergy.2013.3.4.215. Epub 2013 Oct 31.
严重药物性皮肤反应:临床模式、诊断与治疗
J Dtsch Dermatol Ges. 2009 Feb;7(2):142-60; quiz 161-2. doi: 10.1111/j.1610-0387.2008.06878.x.
4
Processes of care desired by elderly patients with multimorbidities.患有多种疾病的老年患者所期望的护理过程。
Fam Pract. 2008 Aug;25(4):287-93. doi: 10.1093/fampra/cmn040. Epub 2008 Jul 14.
5
SCORTEN: does it need modification?
Indian J Dermatol Venereol Leprol. 2008 Jan-Feb;74(1):35-7. doi: 10.4103/0378-6323.38405.
6
Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN.
Br J Dermatol. 2007 Dec;157(6):1294-6. doi: 10.1111/j.1365-2133.2007.08222.x. Epub 2007 Oct 4.
7
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:以近期上市药物为重点评估用药风险。欧洲严重皮肤不良反应研究(EuroSCAR研究)
J Invest Dermatol. 2008 Jan;128(1):35-44. doi: 10.1038/sj.jid.5701033. Epub 2007 Sep 6.
8
Severe cutaneous adverse reactions to drugs.药物引起的严重皮肤不良反应。
Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):304-9. doi: 10.1097/ACI.0b013e328216f54a.
9
Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
Semin Cutan Med Surg. 2006 Jun;25(2):91-3. doi: 10.1016/j.sder.2006.04.004.
10
[Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin].[中毒性表皮坏死松解症的治疗。9例患者应用静脉注射免疫球蛋白的经验]
Hautarzt. 2006 Mar;57(3):185-6, 188-90, 192-4. doi: 10.1007/s00105-006-1104-0.